Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon P L Travis

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Journal of Crohn'S & Colitis|December 3, 2010
The pattern and outcome of acute severe colitisLotte C Dinesen, Alissa J Walsh, Marijana Nedeljkovic Protic, et al.
Intestinal Research|February 10, 2018
Are Truelove and Witts criteria for diagnosing acute severe colitis relevant for the Indian population? A prospective studySaransh Jain, Saurabh Kedia, Sawan Bopanna, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 18, 2024
Hypercoagulation after Hospital Discharge in Acute Severe Ulcerative Colitis: A Prospective StudyBenjamin J Griffiths, Michael J R Desborough, Marjolijn Duijvestein, et al.
Journal of Crohn'S & Colitis|November 19, 2016
Beyond Histological Remission: Intramucosal Calprotectin as a Potential Predictor of Outcomes in Ulcerative ColitisMarianne Guirgis, Emily Wendt, Lai Mun Wang, et al.
Inflammatory Bowel Diseases|November 11, 2023
Exclusive Enteral Nutrition Mediates Beneficial Gut Microbiome Enrichment in Acute Severe ColitisAditya Bajaj, Manasvini Markandey, Mukesh Singh, et al.
Digestive Diseases and Sciences|June 28, 2018
Potential of Fecal Calprotectin as an Objective Marker to Discriminate Hospitalized Patients with Acute Severe Colitis from Outpatients with Less Severe DiseaseSaurabh Kedia, Saransh Jain, Sandeep Goyal, et al.
Journal of Gastroenterology and Hepatology|August 15, 2017
Limited uptake of ulcerative colitis "treat-to-target" recommendations in real-world practiceRobert V Bryant, Samuel P Costello, Scott Schoeman, et al.
Gut|February 26, 2013
Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II studySimon P L Travis, Silvio Danese, Limas Kupcinskas, et al.
The American Journal of Gastroenterology|August 17, 2011
The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: safetyGert Van Assche, James D Lewis, Gary R Lichtenstein, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 26, 2020
Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitisEmma L Culver, Helen K Bungay, Margaret Betts, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Journal of Crohn'S & Colitis|December 3, 2010
The pattern and outcome of acute severe colitisLotte C Dinesen, Alissa J Walsh, Marijana Nedeljkovic Protic, et al.
Intestinal Research|February 10, 2018
Are Truelove and Witts criteria for diagnosing acute severe colitis relevant for the Indian population? A prospective studySaransh Jain, Saurabh Kedia, Sawan Bopanna, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 18, 2024
Hypercoagulation after Hospital Discharge in Acute Severe Ulcerative Colitis: A Prospective StudyBenjamin J Griffiths, Michael J R Desborough, Marjolijn Duijvestein, et al.
Journal of Crohn'S & Colitis|November 19, 2016
Beyond Histological Remission: Intramucosal Calprotectin as a Potential Predictor of Outcomes in Ulcerative ColitisMarianne Guirgis, Emily Wendt, Lai Mun Wang, et al.
Inflammatory Bowel Diseases|November 11, 2023
Exclusive Enteral Nutrition Mediates Beneficial Gut Microbiome Enrichment in Acute Severe ColitisAditya Bajaj, Manasvini Markandey, Mukesh Singh, et al.
Digestive Diseases and Sciences|June 28, 2018
Potential of Fecal Calprotectin as an Objective Marker to Discriminate Hospitalized Patients with Acute Severe Colitis from Outpatients with Less Severe DiseaseSaurabh Kedia, Saransh Jain, Sandeep Goyal, et al.
Journal of Gastroenterology and Hepatology|August 15, 2017
Limited uptake of ulcerative colitis "treat-to-target" recommendations in real-world practiceRobert V Bryant, Samuel P Costello, Scott Schoeman, et al.
Gut|February 26, 2013
Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II studySimon P L Travis, Silvio Danese, Limas Kupcinskas, et al.
The American Journal of Gastroenterology|August 17, 2011
The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: safetyGert Van Assche, James D Lewis, Gary R Lichtenstein, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 26, 2020
Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitisEmma L Culver, Helen K Bungay, Margaret Betts, et al.
Pageof 9